Genomic and experimental evidence that ALKATI does not predict single agent sensitivity to ALK inhibitors
Summary: Genomic data can facilitate personalized treatment decisions by enabling therapeutic hypotheses in individual patients. Mutual exclusivity has been an empirically useful signal for identifying activating mutations that respond to single agent targeted therapies. However, a low mutation freq...
Saved in:
Main Authors: | Haider Inam, Ivan Sokirniy, Yiyun Rao, Anushka Shah, Farnaz Naeemikia, Edward O'Brien, Cheng Dong, David M. McCandlish, Justin R. Pritchard |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f98a7049c703493fbae9b06d38862432 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- NPJ systems biology and applications
-
Thrombolytic Agents: Nanocarriers in Targeted Release
by: Minghua Shen, et al.
Published: (2021) -
Logical and experimental modeling of cytokine and eicosanoid signaling in psoriatic keratinocytes
by: Eirini Tsirvouli, et al.
Published: (2021) - Communications biology
-
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
by: Jonathan Li, et al.
Published: (2021)